In this blog we are going to tell you about Patientportal Aegislabs.com, so read this blog carefully to get the complete information.
In order to accurately establish whether a patient needs testing, AEGIS is urging that any of their patients who are reporting Covid-19 viral adverse symptoms consult their primary care physician first. Your PCP, who is the expert on you and your medical background, will want to take into account all factors.
In addition to enabling you to stay in your house while you’re feeling under the weather, testing at home also stops the spread of any germs around the neighbourhood. From the moment tests are entered onto their research laboratory tracking system until test results are sent, the Aegis TAT is estimated. The time spent getting to the lab is excluded.
In order to increase the use of overnight transportation to its lab following collection, All Aegis collaborates with its collection partners. The interval between the collecting event and the final Aegis report may be impacted by shipping delays and end-of-week delivery schedules.
What is Aegis?
Aegis Sciences Corporation, a healthcare industry leader, stated that it has gained registration and clearance to report COVID-19 diagnostic test findings for public health objectives to State Departments of Health in all 50 U.S. states. Additionally, the firm offers scientifically advanced drug compliance testing and counselling services to clinicians. Aegis Sciences Corporation, based in Nashville, Tenn., is a laboratory sciences company that provides science-driven testing and consulting services to clients throughout the United States, including healthcare providers, pharmaceutical companies, professional and amateur sports organisations, leading college and university athletic programmes, Fortune 500 corporations, and government agencies. Please visit http://www.aegislabs.com/ for further details.
The firm has increased access to COVID-19 testing and made it available across the country since making its COVID-19 diagnostic test available on April 15 by utilising its diagnostic expertise and geographic reach. Aegis Sciences can presently execute 10,000 COVID-19 tests per day and more than 300,000 tests per month with an average turnaround time of 24 hours.
Visit www.aegislabs.com for additional information and specifics on how to use Aegis’ COVID-19 testing service, contact COVIDtest@aegislabs.com, or call 615-99COVID (615.992.6843).
What is patientportal.aegislabs.com all about?
In light of the COVID-19 pandemic, the medical services sector has developed a few diagnostic techniques to identify the SARS-CoV-2 virus in persons who are now sick and antibodies in those who have previously been infected. These tests were written in a record amount of time. Nonetheless, as we understand more about the virus, their accuracy improves. Medical professionals must fully comprehend each technique in order to assure genuine test administration, procedural viability, and accurate result reporting.
Methods of testing:
- Molecular testing
Molecular techniques identify RNA from the SARS-CoV-2 virus to determine whether a COVID-19 infection is active or acute. The nucleic acid amplification test (NAAT), real-time reverse transcription-polymerase chain reaction (RT-PCR), and loopâ€TMmediated isothermal amplification are among examples (LAMP). Nasopharyngeal, deep nasal, anterior nares, and oropharyngeal collecting routes are also possible. Molecular test experimental results can be acquired in 3 to 4 hours or as long as seven days, depending on lab capacity; the typical time is 1 to 2 days.
Advantages
- Molecular testing, including RT-PCR, are regarded as the gold standard for detecting the SARS-CoV-2 virus.
- Molecular assays are also used as confirmatory tests following antigen testing since they are extremely accurate with response and are more prevalent than 95%.
- RT-PCR is less likely to produce false negatives than other testing modalities, according to research.
- The RT-PCR test is also useful in determining if an individual has a current COVID-19 infection detectable in their test sample.
- If this is true, they are assumed to be irresistible when the sample is collected.
Disadvantages
- According to reports, the accuracy of RT-PCR findings is strongly dependent on sample collection timing, type, capacity, handling, and processing.
- The tests only look for current infection. They are unable to determine whether a person has already been infected.
- A false negative result is possible if the sample is not adequately acquired or if a subject is tested too soon after exposure to the pathogen or after the point of no return in their infection.
- Antigen testing
Antigen testing identify surface proteins from the SARS-CoV-2 virus to determine whether an infection is active or acute. The nasopharynx and front nares are used to collect specimens. Antigen testing are advised for those who experience symptoms within the first 5 to 7 days of infection. Nonetheless, a Cochrane systematic review of 22 antigen test investigations revealed that their sensitivity ranged from 0% to 94%, with the average sensitivity being 56.2%, which is why a confirmatory RT-PCR test is recommended. Antigen testing offer findings faster than molecular tests; point-of-care tests produce results in 15 to 30 minutes.
Advantages
- Similarly, antigen testing are less expensive than RT-PCR assays and do not require a specific lab method.
- Antigen testing allows for rapid screening and detection of COVID-19 in high-risk populations and environments.
- According to the Centers for Disease Control and Prevention (CDC), the sensitivity of antigen testing varies among the tests that have been approved for emergency use.
Disadvantages
- Despite the short turnaround time for antigen testing results, a significant drawback in many networks is the lack of widely available and reasonably priced at-home testing kits.
- Most antigen tests are conducted in a hospital clinic, facility, or drug shop, which necessitates travel time to and from the testing location.
(C) Antibody Testing
To identify a past infection, antibody testing, which needs a blood test from a vein or a finger prick, is used.
These tests are carried out using lateral flow or immunoassay assays, such as the ELISA (chemically connected immunodeficient examination) and the CIA (chemically connected immunodeficient examination) (chemiluminescent immunoassay). Antibody testing can determine if immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies were produced in response to the illness.
Before usage, the FDA does not formally evaluate the display of immunizer tests that are not commercially promoted. Regardless, emergency use authorisation is necessary for commercially available antibody testing.
Advantages
- Asymptomatic patients who had previously been infected can be identified via antibody testing.
- This data is critical for guiding transmission control measures like as quarantine, imprisonment, and social isolation, as well as the closure of schools, places of worship, and offices.
- Another advantage of antibody testing is that it can help with immunisation formulation and adequacy.
- The testing can determine which components of the virus the immune system reacts to and which should be targeted during vaccine development.
Disadvantages
- The association of antibody levels with immunity is a key limitation of antibody assays.
- Testing positive for IgG antibodies, which indicates recovery from COVID-19 infection, does not guarantee protection against re-infection.
- Because patients with IgG antibodies may still contain and spread the virus, they should continue to follow CDC guidelines for mask use, hand hygiene, and social isolation.
Check Patientportal.Aegislabs.Com For The Latest Updates:
When the sample is received in the research facility and testing begins, the portal will indicate that the sample has been received and testing is beginning. When testing is completed, the results will be available in the site. When your test results are revealed, you will also receive an email with your results.
Around the last year, a large number of people all over the world have been infected with illnesses unrelated to the spread of SARS-CoV-2. Despite crucial advancements in knowledge about the virus that causes COVID-19, medical providers, disease transmission experts, virologists, and lab researchers have repeatedly found themselves in a tough struggle in preventing the spread of COVID-19 and treating people afflicted with it.
Aegis Sciences Corporation will continue to produce extremely sensitive and precise diagnostic test findings within a clinically meaningful turnaround time, as it has done with over 3 million tests performed to date. Throughout the Pandemic, certain groups of clinical and research centre researchers will continue to monitor the logical writing and clinical ideas for testing, as is customary.